Clinical Trial: The Effect of Metformin As an Adjuvant Therapy on Immunological Parameters in Egyptian Patients with RRMS: a Pilot Study

U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT06812585) titled 'The Effect of Metformin As an Adjuvant Therapy on Immunological Parameters in Egyptian Patients with RRMS: a Pilot Study' on Feb. 02.

Brief Summary: This pilot study aims to investigate the tolerability and feasibility of using metformin as an adjuvant treatment for RRMS. Also, it aims to evaluate the preliminary evidence of its efficacy by analyzing outcomes related to immunology, clinical manifestations, and radiological findings.

Study Start Date: April 01, 2022

Study Type: INTERVENTIONAL

Condition: Multiple Sclerosis (MS) - Relapsing-remitting

Intervention: DRUG: Metformin (Cidophage(R))

Antidiabetic agent used to treat ty...